Latest filing published 03 Jun 2009 for ALEXION PHARMACEUTICALS INC, €35k.
Insider track record
No signal scores available.
David W. Keiser: trading record in brief
David W. Keiser discloses dealings in Alexion Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 9 January 2006 to 1 June 2009, the count stands at 148 filings.
The open-market record consists of 100 sales worth €14.9M, with no purchase. Outside the open market, there are 11 share grants and 37 option exercises. Since January 2009: no purchases and 25 sales on the market.
On 3 June 2009 came the latest disclosure, an option exercise for €35k in Alexion Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David W. Keiser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,440 shares@ US$20.58Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:0
- 4,810 shares@ US$20.58Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:1
- 17,500 shares@ US$20.83Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:2
- 15,250 shares@ US$32.25Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:3
- 38,200 shares@ US$36.59Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:4
- 1,800 shares@ US$37.25Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:5
- 10,000 shares@ US$36.63Common Stock, par value $.0001 per shareSEC:0001231977-09-000055:6
- 7,800 shares@ US$35.01Common Stock, par value $.0001 per shareSEC:0001231977-09-000048:0
- 2,200 shares@ US$35.00Common Stock, par value $.0001 per shareSEC:0001231977-09-000047:0
- 7,000 shares@ US$13.79Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:0
- 1,250 shares@ US$10.36Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:1
- 16,500 shares@ US$16.35Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:2
- 15,250 shares@ US$20.58Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:3
- 38,100 shares@ US$32.77Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:4
- 1,900 shares@ US$33.40Common Stock, par value $.0001 per shareSEC:0001231977-09-000046:5
- 10,822 shares@ US$10.50Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:0
- 1,178 shares@ US$10.50Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:1
- 1,000 shares@ US$10.19Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:2
- 14,240 shares@ US$11.65Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:3
- 5,760 shares@ US$11.65Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:4
- 7,000 shares@ US$13.79Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:5
- 24,000 shares@ US$35.92Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:6
- 16,000 shares@ US$36.76Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:7
- 696 shares@ US$35.95Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:8
- 5,200 shares@ US$36.00Common Stock, par value $.0001 per shareSEC:0001231977-09-000043:9
25 of 146 declarations